Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment

An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis to non-alcoholic steatohepatitis (NASH). NASH is a chronic state of liver inflammation that leads to the transformatio...

Full description

Bibliographic Details
Main Authors: Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Medicine
Subjects:
NAFLD
liver fibrosis
liver biopsy
non-invasive assessment
liver stiffness
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.615978/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.615978/full

Similar Items